Skip to main content
Impact Dashboard

The numbers behind the work.

Updated quarterly. Every figure is drawn from our own data, tracked through Essyl, our HIPAA-compliant care coordination platform. We publish these numbers because accountability is part of what we stand for.

Last updated · Q1 2026Next update · Q2 2026
Cumulative impact

Since 2019, all sites, all neighborhoods.

2,340+

Cardiometabolic screenings and health education sessions across Greater Boston between 2023 and 2025.

1,500+

Total participants served.

47+

Hypertensive crises caught early, and patients connected to providers and hospitals for care to prevent more serious problems.

19+

Active screening sites across 10 Greater Boston neighborhoods.

6

Community languages spoken by our health worker team.

Current year (FY2025)

What this year looks like, refreshed each quarter.

1,302

Screenings delivered in 2025.

879

Unique participants served in 2025.

22

Hypertensive crises caught early in 2025, and patients connected to providers and hospitals for care to prevent more serious problems.

25.5%

Our participant retention rate is 3.2 times higher than the industry baseline of 8%.

52%

Retention rate at our East Boston site.

Dose-response

Blood pressure improvement by visit frequency.

The more consistently someone engages, the better their outcomes. This is the dose-response we document and track across every site.

1–2 visits26.6%

of participants show meaningful blood pressure improvement.

6–9 visits74%

of participants show meaningful blood pressure improvement.

Cost and value

$111 per screening. Eight to twenty-nine dollars returned for every one invested.

$111

Fully loaded cost per screening, including health coach time, equipment, follow-up, documentation, and care coordination.

$60

Program-only cost per screening.

8:1–29:1

Total program return on investment. For every dollar invested, the health system receives between eight to twenty-nine dollars in value through crises prevented, hospitalizations avoided, and medications taken.

Growth

304%

Screening growth from 2022 to 2025.

22%2022
42%2023
68%2024
89%2025

Relative screening volume, indexed to 2025. Static asset, refreshed quarterly.

Geography

We currently operate in:

MattapanDorchesterRoxburyEast BostonHyde ParkBrockton
Data integrity

All figures on this page come from Essyl.

HGF’s bespoke HIPAA-compliant care coordination platform. Data is reviewed and approved by HGF leadership before each quarterly update. Figures reflect the most recent completed reporting period.

For questions about our data methodology, contact us at data@heartofagiant.org.

Reports & methodology

The full reports, with methodology.

Quarterly briefs, the annual impact report, and the underlying methodology live on our Resources page. Request the raw dataset by emailing data@heartofagiant.org.

What the data means

Numbers without context are easy to dismiss.

If you want to understand what these figures mean in practice, start here.